Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Elliot Tapper MD

Elliot B. Tapper MD

Assistant Professor, Medical School, Internal Medicine » Gastroenterology & Hepatology, University of Michigan, Ann Arbor, Michigan

Elliot Tapper, MD, is Associate Professor at the University of Michigan where he directs the Michigan Cirrhosis Program. Dr. Tapper is known for innovative outcomes research and landmark studies in the epidemiology of cirrhosis. His research, funded by the NIH and PCORI, focuses on improving clinical and patient reported outcomes for patients with chronic liver disease through clinical trials and quality improvement. He is Editor-in-Chief of Hepatology Communications.


Dr. Tapper reports the following:

  • Consulting: Bausch, Mallinckrodt, Axcella, Novo Nordisk, Ambys, Lipocine, Kaleido, Takeda.
  • Grants: Bausch, Gilead